BCRX BioCryst Corp: Uzoq muddatli qarzning kapitalga koeffitsiyenti

BioCryst Corp (BCRX) brendining ramzi va logotipi

BioCryst Pharmaceuticals kompaniyasi irsiy angioedemaga qarshi ishlanmalarining muvaffaqiyati va patent himoyasiga tayangan holda, kam uchraydigan patologiyalar terapiyasi bilan shug'ullanadi. Retsept bo'yicha savdoning o'sishi orqali biznesni kengaytirish marketing xarajatlarini optimallashtiradi, bunda joriy ko'rsatkich 0.00 ni tashkil etadi. Yuqori R&D xarajatlari va FDA ning qat'iy nazorati bozorga kirish uchun jiddiy to'siqlarni yaratadi. Alohida uzoq muddatli qarzlarning narx dinamikasi quyidagi grafikda aks ettirilgan.

BCRX - BioCryst Pharmaceuticals, Inc. Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022 - 27.10.2026 oraligʻida

BioCryst (BCRX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Kotirovkalar grafigi BioCryst Pharmaceuticals, Inc.|BCRX - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati BioCryst Pharmaceuticals|BCRX - Korxona qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati BioCryst|BCRX - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati biocryst.com|BCRX - Kompaniyaning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati BioCryst|BCRX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati biocryst.com|BCRX - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati BioCryst Pharmaceuticals
Kompaniyaning dastlabki tahlili:BCRX, BioCryst Pharmaceuticals, Inc.
BioCryst asosiy tovari

BioCryst (BCRX) innovatsion dori vositalariga bo'lgan barqaror talab tufayli makroiqtisodiy zarbalardan himoyalangan holda qolmoqda, bu esa biznesni chidamli defensiv aktivga aylantiradi. Uzoq muddatli qarzning kapitalga nisbati tahlili moliyalashtirish tuzilmasidagi qarz mablag'larining ulushini baholash imkonini beradi, bunda past ko'rsatkichlar defolt xatarlarining yo'qligini va emitentning moliyaviy avtonomiyasini tasdiqlaydi, bu esa kompaniyaning to'lov qobiliyatini uzoq muddatli baholash uchun juda muhimdir.

Toʻgʻridan-toʻgʻri raqobatchilar

Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati argenx N.V.|BioNTech Group (BNTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Abivax S.A. (ABVX)|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|protagonist-inc.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunovant (IMVT)|KNSA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|GRFS (Grifols Group) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Adaptive Biotechnologies Inc. (ADPT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com (AUPH)|Vera Therapeutics (VERA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Dianthus Therapeutics Inc (DNTH)|Uzoq muddatli qarzning kapitalga nisbati PHVS|AbCellera - Uzoq muddatli qarzdorlikning kapitalga nisbati|TRML: Uzoq muddatli qarzning o'z kapitaliga nisbati|PGEN: Uzoq muddatli qarzning o'z kapitaliga nisbati|PHAR (Pharming Group) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ZBIO|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunome, Inc. IMNM|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi gossamerbio.com (GOSS)|KALV: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Septerna, Inc. SEPN|PVLA - Uzoq muddatli qarzning kapitalga nisbati|SVRA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Rigel Pharmaceuticals - Uzoq muddatli qarzning kapitalga nisbati|ANAB (anaptysbio.com) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ATXS (Astria Therapeutics, Inc.)|Uzoq muddatli majburiyatlarning kapitalga nisbati enGene Holdings Inc|Uzoq muddatli qarzning kapitalga nisbati RAPT (RAPT Therapeutics, Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati JBIO (aerovatetx.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati Aclaris Therapeutics|KYTX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|TLSA (Tiziana Life Sciences Ltd) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CABA: Uzoq muddatli majburiyatlarning kapitalga nisbati|Ventyx Bio - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Theratechnologies, Inc|Avalo Therapeutics, Inc (AVTX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati eledon.com|Uzoq muddatli qarzning kapitalga nisbati Agenus Inc. (AGEN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Climb Bio Inc. (CLYM)|Zura Bio Limited - Uzoq muddatli qarzning kapitalga nisbati|aTyr Pharmaceuticals - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adagene Corp (ADAG)|ImageneBio Inc (IMA) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati shattucklabs.com|EQ (Equillium) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Connect Biopharma Holdings CNTB|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati Immunic Inc|Atara Biotherapeutics (ATRA) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti inflarx.de (IFRX)|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|Adicet Bio Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Celularity Corp (CELU)|INMB: Uzoq muddatli qarzning kapitalga koeffitsiyenti|BRNS (Barinthus Biotherapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|kezarlifesciences.com (KZR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|SABS (SAB Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Akari Therapeutics PLC (AKTX)|Enlivex Therapeutics (ENLV) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti q32bio.com (QTTB)|Uzoq muddatli qarzning kapitalga nisbati GOVX|edesabiotech.com - Uzoq muddatli qarzdorlikning kapitalga nisbati|IBIO: Uzoq muddatli qarzning o'z kapitaliga nisbati|CARM: Uzoq muddatli qarzning o'z kapitaliga nisbati|XTLB (XTL Biopharmaceuticals, Ltd.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Bolt Biotherapeutics, Inc.|HCWB (HCW Biologics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati APVO|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech AIM|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi aditxt.com (ADTX)|GRI: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati XORTX Corp XRTX|HIND - Uzoq muddatli qarzning kapitalga nisbati|REVB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Indaptus Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|SCNI (Scinai Immunotherapeutics Ltd) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CALI (CalciMedica Inc)|Uzoq muddatli majburiyatlarning kapitalga nisbati Affimed Therapeutics|Uzoq muddatli qarzning kapitalga nisbati ALLK (Allakos Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati HOOK (hookipapharma.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati IGM Biosciences|ITOS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|OCEA (Ocean Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati|TCBP: Uzoq muddatli majburiyatlarning kapitalga nisbati|Third Harmonic Bio - Uzoq muddatli qarzning o'z kapitaliga nisbati